Untangling Alzheimer's Disease

Thought Leader: Prof. Claude Wischik, M.D., Ph.D., TauRx Therapeutics

In this episode, Professor Wischik describes his ongoing journey of research and development for Alzheimer's Disease. This intriguing podcast covers the man, the molecule, and the market.

For more information about TauRx Therapeutics, visit www.taurx.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Biosimilar Development

Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International

In this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard.

For more information about PRA International, visit www.prainternational.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Networked Drug Development - Bringing Assets, Capital and Services Together

Date Posted: 5/31/2011
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research

In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.